Drotaverine in Dysmenorrhoea Treatment

NCT00292747 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

480

Enrollment

INDUSTRY

Sponsor class

Stopped early termination due to loss of interest and low enrollment of patient

Conditions

Dysmenorrhea

Interventions

DRUG: Drotaverine
DRUG: Drotaverine Placebo
DRUG: Ibuprofen
DRUG: Ibuprofen Placebo

Sponsor

Sanofi